Results 101 to 102 of about 169,093 (102)
Some of the next articles are maybe not open access.
Phase 2 trial of SL-701 in relapsed/refractory (r/r) glioblastoma (GBM): Correlation of immune response with longer-term survival.
, 2018 D. Peereboom, L. Nabors, P. Kumthekar, M. Badruddoja, K. Fink, F. Lieberman, S. Phuphanich, E. Dunbar, T. Walbert, D. Schiff, D. Tran, L. Ashby, N. Butowski, F. Iwamoto, R. Lindsay, J. Bullington, M. Schulder, J. Sherman, T. Goswami, D. Reardon +19 moresemanticscholar +1 more sourceFIERCE-21: Phase 1b/2 study of docetaxel + b-701, a selective inhibitor of FGFR3, in relapsed or refractory (R/R) metastatic urothelial carcinoma (mUCC).
, 2018 J. Bellmunt, J. Picus, M. Kohli, Y. Arriaga, M. Milowsky, G. Currie, S. Abella, S. Pal +7 moresemanticscholar +1 more source
